Pemigatinib for previously treated locally advanced/metastatic cholangiocarcinoma (CCA): Update of FIGHT-202
Abou-Alfa, Ghassan K., Sahai, Vaibhav, Hollebecque, Antoine, Vaccaro, Gina M., Melisi, Davide, Al-Rajabi, Raed Moh'd Taiseer, Paulson, Andrew Scott, Borad, Mitesh J., Gallinson, David H., Murphy, Adrian Gerard, Oh, Do-Youn, Dotan, Efrat, Catenacci, Daniel, Van Cutsem, Eric, Lihou, Christine Francis, Zhen, Huiling, Féliz, Luis, Vogel, Arndt
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
A randomized, phase II, multicenter, double-blind, placebo-controlled study evaluating onartuzumab (MetMAb) in combination with mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer
Bendell, Johanna C., Ervin, Thomas J., Gallinson, David H., Singh, Jaswinder, Wallace, James Alfred, Saleh, Mansoor N., Vallone, Marcy, Hack, Stephen Paul
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article